HempNewsBreaks – Youngevity International, Inc. (NASDAQ: YGYI) Subsidiaries Enter Joint Venture for Large Scale Processing Facility, 2,200 Acres to Grow Hemp in Nicaragua

Youngevity International (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, commercial hemp enterprise and multi-channel lifestyle company, today announced that its wholly-owned subsidiaries, CLR Roasters LLC and Khrysos Industries, Inc. (the “US Partners”) have entered into an agreement with H&H Coffee Group Export Corp and The Nica Hemp Cooperative, Inc (the “Nicaragua Partners”) to acquire the 2,200 acre Chaguitillo Farms in Sebaco-Matagalpa, Nicaragua. The joint venture will utilize the property to erect a large-scale processing facility and to grow hemp on the land. Planned improvements to the property are anticipated to total approximately $30,000,000 dollars, with H&H contributing the 2,200-acre farm with an estimated value of about $10 million. All the capital toward the construction of the project, estimated at $20 million dollars, will be provided by The Nica Hemp Cooperative. Along with its expertise in the hemp business, the US Partners will initially contribute $3,000,000 of extraction equipment to the project. Additionally, the US Partners aim to issue 1.5 million shares of YGYI common stock to the Nica Hemp Cooperative in exchange for a 50% stake in the land and the improvements (having a $30,000,000 estimated value at completion). The US Partners will also issue 5 million warrants with a strike price $1.50 per share to the Nica Hemp Cooperative in exchange for a 75% controlling stake in the hemp grow and oil extraction business, subject to Nasdaq approval. The warrants will be issued when the project is completed and initiates its operations. “This is a very impressive partnership and collaboration between our Hemp Enterprise, our Coffee Enterprise and our very strong and growing strategic business relationship in Nicaragua. We feel that the value of YGYI’s 50% interest in the land and infrastructure at completion of the project along with the assumption that the warrants will be exercised represents a significant premium to our current trading price,” Youngevity president and CFO Dave Briskie stated in the news release.

To view the full press release, visit http://cnw.fm/KJiE9

About Youngevity International, Inc.

Youngevity International, Inc. is a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise. The company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity. YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For more information, please visit www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Files New Patent Application for DehydraTECH Technology in Delivery of Antiviral Drugs

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that it has filed an important new patent application in the United States describing the use of its DehydraTECH(TM) technology for the delivery of antiviral drugs. According to the update, the technology would potentially be used to improve treatment options for viral infectious diseases including COVID-19, MERS, SARS, influenza, herpes, hepatitis and AIDS. “Lexaria’s proprietary drug delivery platform has already proven its effectiveness in the oral delivery of other lipophilic drugs such as nicotine, cannabinoids, and more, with multi-fold increases in both the rate and extent of bioabsorption,” Lexaria President John Docherty said in the news release. “We hypothesize that, once detailed testing begins, DehydraTECH will evidence improvements in the quantity and rapidity with which certain antiviral drugs are able to reach the human bloodstream after oral delivery. This has the potential to make a real contribution in the fight against COVID-19.”

To view the full press release, visit http://cnw.fm/9fGWH

About Lexaria

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way API’s enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and can reduce drug costs for orally administered bioactive molecules including nicotine, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and other molecules. Lexaria has licensed DehydraTECH to multiple companies for use in various oral application formats, including to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a federally licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Ohio Eases Medical Marijuana Purchase Restrictions

The state of Ohio has eased some of its medical marijuana restrictions after repeated complaints that the current system made it difficult for patients to get their medicine when they needed it. The need for a system that works for the patients was further underscored by the danger posed by the Coronavirus pandemic. It forced people to leave the confines of their homes more often than they would have liked, putting them at a greater risk of contracting the virus.

Most medical marijuana patients have weakened immunities due to advanced age and/or serious medical conditions, and they are the last people who should be out and about. State regulations limit patients to a 90 day supply, but soon after the state’s medical-marijuana program picked up some steam, patients noticed something.

They ‘lost’ the days they hadn’t purchased any medical marijuana. So if a patient went to the dispensary on day 30, they would only be able to buy 60 days’ worth of marijuana, effectively losing the first thirty days’ worth. Additionally, any purchases made in the last 90 days were subtracted as patients had to wait for purchases to ‘fall off’ after 90 days before they could purchase more.

On top of that, the patient portal showed an inaccurate number of remaining days, resulting in a system that prevented customers from getting the 90 days’ worth of marijuana they were entitled to.

“I can go for several weeks without buying anything from my local dispensary. Meanwhile, my 90-day purchasing window is getting smaller,” says Ted McLaughlin, a Vietnam War veteran.

“Under the old purchase limits, I had to take several trips to my dispensary in Cleveland rather than being able to stock up all at once,” he says. Patients won’t have to worry about that now after the state made the rules less restrictive.

A patient will now be able to buy 45 days’ worth of products at any point in a 45 day period. And unlike in the previous system, they won’t lose their unpurchased days. Additionally, they won’t carry over to the next period. So if a patient goes to the dispensary on day 30, they can buy 45 days’ worth of marijuana, come back on day 46 and purchase another 45 days’ worth.

“We hope this will provide greater transparency for patients, caregivers, and dispensary employees while still taking steps to ensure patients do not possess more than a 90-day supply as stipulated in the Ohio Revised Code,” says Pharmacy Board spokesman Cameron McNamee.

These changes are likely to be welcomed by the entire marijuana industry, including Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), since it has always been a goal of the industry to serve patients in the best way possible, and Ohio’s reforms do just that.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – How Criminalizing Marijuana is Undermining COVID-19 Response Efforts

The Coronavirus crisis has shown just how unprepared we all were for a pandemic. To be fair, though, the last time we faced something quite like this was 100 years ago. The most we can do now is try to mitigate the spread of the virus and pick up the pieces when we emerge on the other side.

At the moment, the federal and state governments have implemented various policies to help flatten the curve and reduce the virus’s impact. These range from promoting self-isolation and social distancing to closing down all but the most essential businesses. However, according to Steve Hawkins, Marijuana Policy Project Executive Director, one public policy that will ultimately undermine the Coronavirus response is marijuana criminalization.

Although some police departments and prosecutors have already determined that prosecuting low-level offenses such as cannabis possession is counterintuitive and puts police, prosecutors and the public at risk, there have been news reports that indicate arrests for marijuana possession have continued.

“As governments work to minimize the negative impacts of COVID-19, it’s clear that punitive cannabis laws and unnecessarily strict regulations serve as far more of a hindrance than a help,” he says. It greatly increases the risk of exposure to the virus for both the users and law enforcement personnel.

Hawkins stresses that keeping the virus out of the country’s infamously overcrowded prisons should be a top priority, especially given how quickly it would spread within the inmates. “It would be a disaster if the Coronavirus becomes prevalent in America’s overcrowded jails and prisons,” he says.

“Criminal justice reform organizations have called for the release of low-risk inmates such as those convicted of cannabis offenses. This step should be taken as swiftly as possible to protect all staff and inmates at correctional facilities.”

The virus has also had a catastrophic effect on the economy, with more than 20 million Americans losing their jobs in a little over a month. Most experts project tough times ahead, with the IMF stating that the crisis is the worst economic decline since the Great Depression of the 1930s.

The state-legal cannabis sector employs more than 200,000 people, a lot of whom are still working after cannabis was deemed essential. The industry could help kickstart the economy through tax revenue as well as by providing gainful employment.

“As we all take time to re-evaluate our nation’s public policy priorities, cannabis and criminal justice should be more important parts of the conversation,” states Hawkins.

“Policymakers, including state legislators, governors and members of Congress, should take advantage of this opportunity to acknowledge that cannabis prohibition does not protect public health and safety, and they should support enacting reasonable policy alternatives on both a temporary and permanent basis.”

Experts think the cannabis industry, including players like Round Meadow Holdings Corp. and Sugarmade Inc. (OTCQB: SGMD), shares the sentiments expressed by the head of the Marijuana Policy Project.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

The Economic Cost of Not Legalizing Marijuana in the U.S.

The possible benefits of states legalizing marijuana are clear from tax revenues collected by states that have legalized it. Besides increased revenues, legal marijuana provides jobs all through the value chain. Failure to legalize weed creates bottlenecks that impede the full exploitation of the potential benefits the marijuana industry affords the economy. Prohibition also causes governments to spend money on enforcement. The following are some details on what the U.S. is losing, and the good marijuana revenue can do.

How much is the U.S. losing each year by opposing marijuana legalization?

According to research, the Federal Government lost $25.64 billion in forfeiture of revenue and in the money spent on enforcing the ban. The country lost, even more, when the losses incurred by individual states were factored in as the states lost $10.05 billion. These losses at the state level also include the money lost in tax revenue and the amount spent in the enforcement of the prohibition.

The composition of these losses may have shifted between loss of revenue and enforcement costs since 2016. The shift would have been occasioned by a change in the general attitude towards marijuana. The drug is now more popular with consumers and more acceptable with authorities. It follows, therefore, that more people are buying it, and this increases the tax revenues it generates. This shift also means that more governments don’t consider enforcing marijuana ban a law enforcement priority, and they, therefore, save on the cost of prohibition. Despite these shifts in dynamics, the amount of losses incurred could only have increased over time.

How can we spend $53 billion?

The $53 billion lost due to governments’ insistence on banning marijuana is a very substantial amount of money that could have a positive impact on many lives. To put it into perspective, we can have a look at some of the things this amount of money can do.

Coronavirus is the most significant public health headache at the moment, with more than two million cases confirmed to date. The average cost of treating a COVID-19 patient is $1,425. $53 billion could, therefore, fund the treatment for 37,354,386 patients. This might very well be all the people who will ever be infected by the virus, and it would be a welcome Coronavirus-marijuana interaction.
Wearing face masks and sanitizing hands are among the actions in the first line of defense for the prevention of COVID-19. According to a USA Today’s report on March 3th, two bottles of 12 ounces’ sanitizer cost as much as $149. $53 billion is enough to buy about 356 million pairs of bottles of sanitizer, which is enough sanitizer to reach every American. Concerning facemasks, the money can buy 134 million boxes of 20 masks each. There are more than enough masks to reach every single person in the country.

The money can also provide health insurance and food to a substantial number of people who may have lost their livelihoods due to the virus.

Marijuana tax revenue distribution: Some prime examples

The states that levy taxes on marijuana usually have laws governing how they spend the revenue they collect from marijuana. The following are some highlights on how some select states have appropriated marijuana revenues.

Alaska: Alaska marijuana law demands that the state should deploy 50% of marijuana revenues to the Alaska Department of Administration. 25% more is to be used on marijuana education for the general public and in schools. The remaining 25% of revenues are supposed to be deposited to the general fund, where it is spent at the discretion of the state legislature.
California: The bulk of California’s collections from marijuana goes to the youth anti-drug programs at 60%. The remaining 40% is divided equally between Public Service Management and environmental conservation.
Oregon: Oregon allocates 40% of its proceeds from marijuana to K-12 education. 20% is dedicated to mental health and treatment for addiction, while 15% and 5% go to the police and states authority respectively for the prevention of drug abuse.

– This article was provided by Dwight K. Blake, Editor in Chief of AmericanMarijuana.org

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

This article contains Third-Party Content submitted by third parties, including articles submitted through the CNW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of CNW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and CNW does not endorse, guarantee or make representations concerning the accuracy and completeness of all third-party content. You acknowledge that by CNW providing you with this internet portal that makes accessible to you the ability to view third-party content through the CNW site, CNW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. CNW expressly disclaims liability relating to such third-party content. CNW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, CNW reserves the right to remove third-party content at any time in its sole discretion.

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) Offers Hemp You Can Feel(TM) Discounts for 420 – Traditional Cannabis Culture Celebration Day

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced special online discount codes for purchases of Hemp You Can Feel(TM) Coffee on April 20 – the traditional cannabis culture celebration day. According to the update, purchases of all products using code ALLUNITED will yield 25% off all products at the www.HempYouCanFeel.com website. “This is a unique product line based on what we believe to be the most bioavailable infusion technologies in the marketplace,” Cannabis Global CEO Arman Tabatabaei stated in the news release. “The organic coffee is super-premium and sourced directly from South America, and we supervise the roasting, grinding and packaging on-site. But, there is a lot more to the Hemp You Can Feel(TM) coffee story. We have been able to achieve true water solubility without using chemicals or any of the unsophisticated, chemical laded nano-emulsions that are currently being widely used. Our unique combination of hemp extracts produces a coffee product that really needs to be experienced to fully appreciate. Thus we are running these special promotions this week only with immediate shipping, so that consumers can enjoy this unique coffee product.”

To view the full press release, visit http://cnw.fm/Vp4Uh

About Cannabis Global, Inc.

Cannabis Global, Inc. (MCTC) is a Nevada registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, Cannabis Global plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs.

More information on the Company can be viewed at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Recreational Cannabis Advocates in Massachusetts Launch Legal Challenge Against “Non-Essential” Categorization During Lockdown

No one would ever have thought the new decade would dawn like this. Three months into the year, a novel Coronavirus that originated from Wuhan, China has infected over 2 million people and claimed at least 120,000 lives. Experts say the virus could end up infecting over 70% of the world’s population.

Once the gravity of the situation settled in, governments were scrambling to prevent the virus from spreading within their borders. One by one, they ordered lockdowns, requiring people to stay indoors unless they absolutely have to leave, and all but the most essential businesses have had to shut down. In most states that allow marijuana, medical and recreational marijuana were classified as essential businesses.

However, the state of Massachusetts classified recreational pot shops as non-essential, with officials stating it was to prevent out of state individuals from coming in and congesting the shops. A group of marijuana advocates has subsequently challenged Governor Charlie Baker’s order to close the recreational shops.

According to Northeastern University Law Professor Daniel Medwed, the basic legal argument was that for some people, recreational marijuana is as essential as going to the grocery or the pharmacy and that people use and rely on it to manage pain and ease anxiety.

“Some people, especially military veterans, are fearful that if they obtained a formal medical marijuana license that could jeopardize their receipt of federal benefits as marijuana is still illegal at the federal level. So they opt for recreational marijuana to help cure what ails them,” he says.

The advocates, consisting of five recreational marijuana companies and a military veteran who uses marijuana for pain relief, are asking for a declaration from the court that recreational marijuana is essential and an order preventing the governor from keeping the businesses closed. They insist they can implement social distancing, and other sanitization precautions used by liquor and medical marijuana stores.

Medwed suggested restricting access to both medical and recreational dispensaries to Massachusetts residents to prevent out of state infections, which was one of the Governor’s main issues. However, he conceded that the chances of the suit being successful were quite low, stating that the court wouldn’t want to set a precedent that would allow other industries to contest their ‘non-essential’ status.

It seems his prediction was spot on after a judge ruled that Governor Baker did indeed have the authority to close recreational marijuana stores. “It seems reasonable for the governor to be concerned that the relatively few recreational marijuana stores are going to attract high volumes of customers including people traveling from other states,” stated Superior Court Judge Kenneth Salinger.

This court ruling is likely to have come as a disappointment to sector players, such as SinglePoint Inc. (OTCQB: SING), who realize that lots of people who have been benefiting from the closed pot shops will now suffer additional hardships during the lockdowns.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Medical Marijuana Jobs in Pennsylvania Remain Unfilled as Industry Booms

The effects of the Coronavirus pandemic will likely be felt for years to come. Experts say the virus may end up infecting up to 70% of the world’s population, and we may need to have sporadic lockdowns till 2022 to completely eradicate it. It’s safe to say that shutting down most businesses and essentially slowing down consumer spending has had a catastrophic effect on the economy.

With most industries feeling the strain, a lot of businesses have had to let some of their staff go. A record 6 million people filed for unemployment, raising the number of unemployed Americans filing for aid to a whopping 22 million. However, some sectors have thrived amid all the chaos, such as cannabis. Deemed an essential industry by most states that allow marijuana, cannabis businesses have been able to operate unabated during the Coronavirus crisis.

However, cannabis firms in Pennsylvania have run into roadblocks while trying to employ new ‘bud-tenders,’ the staffers who consult with patients. This is despite the fact that more than one in six Pennsylvanians has filed for unemployment since the Coronavirus shutdowns began.

Prospective employees require FBI background checks and drug tests, but most of the offices that process fingerprints are shut down for the time being. “It’s just so unbelievably frustrating. I have five clients with over 100 openings, and there are likely hundreds more that are waiting. These are good-paying jobs, many of which come with health care benefits,” says Harrisburg lawyer Judith Cassel.

She sent a letter to the state Department of Health, requesting a temporary 90-day waiver that would allow job candidates to sign an affidavit stating they don’t have a criminal record. They would also undergo third-party background checks, and any untruthful responses or failing the test will result in immediate termination.

Cassel stressed on the fact that although these measures were indeed useful, these are special times and they require special solutions. “We understand the need for background checks and department oversight on hires during normal circumstances, but these are not normal times. The current process does not rise to the current challenge.”

This problem isn’t restricted to Pennsylvania only. According to an official with Chicago-based marijuana company Cresco Labs, the firm has had a hard time finding people to fill 250 workers in Illinois.

“Under normal circumstances, it would take two to six weeks to get approved,” says Cresco’s Executive Vice President John Sullivan. “But since most state government functions are closed down and a lot of the fingerprint agencies shut, too, the process is stretching out longer and longer.”

Experts believe that cannabis firms like Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) are frustrated that at a time when jobs are being lost, an industry that can employ more people is being held back by a freeze on crucial processes that are a prerequisite for people to secure the available jobs.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Completes Landmark Shipment of Premium Medical Cannabis Products to Israel

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently completed a landmark shipment containing Supreme Cannabis’ premium medical cannabis product from Canada to Israel (http://cnw.fm/8kJWr). An article discussing the company reads, “Supreme Cannabis interim president and CEO Colin Moore reported that the transaction, which was made possible through a partnership with Breath of Life International (BOL Pharma), represents a new international revenue opportunity for Supreme Cannabis and ‘builds Truverra’s global medical brand in one of the most sophisticated medical cannabis markets in the world.’ . . .‘With the support of BOL Pharma, we navigated both Canada and Israel’s complex regulatory landscapes to achieve compliance with regulatory authorities in both countries, including Health Canada, the Canadian Food Inspection Agency and Israel’s Ministry of Health and Ministry of Agriculture and Rural Development,’ Moore continued. ‘We benefitted from BOL Pharma’s skilled team, international experience and solidified position as a leading medical cannabis company in Israel. As we pursue capital-light international opportunities, we will continue to look to Jeff Adams, Truverra’s CEO, and his exceptional team to build Truverra’s medical brand globally.’”

To view the full article, visit http://cnw.fm/ObE0P

About Supreme Cannabis Company Inc.

Supreme Cannabis is a global, diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the company has emerged as one of the world’s fastest-growing, premium, plant-driven lifestyle companies. Supreme Cannabis’ portfolio of brands caters to diverse consumer experiences, with brands and products that address recreational, wellness, medicinal and new-consumer preferences. The company’s brand portfolio includes 7ACRES, Blissco, Truverra, Sugarleaf by 7AC and Khalifa Kush Enterprises Canada. Supreme Cannabis’ brands are backed by a focused suite of world-class operating assets that serve key functions in the value chain, including scaled cultivation, value-add processing, centralized manufacturing and product testing, and R&D. For more information, visit the company’s website at www.Supreme.ca.

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://cnw.fm/FIRE

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Secures DTC Eligibility

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that its common shares are now fully eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”). Champignon’s common shares will continue to trade under the ticker symbol “SHRMF” on the OTC Markets. “We are actively engaged in pursuing new avenues of distribution both in North America and internationally, in order to enhance the ability of larger audiences to participate in the Champignon story, as well as broaden our already robust shareholder base,” Champignon CEO Gareth Birdsall stated in the news release. “With the receipt of DTC eligibility, our common shares will become accessible to United States investors, both retail and institutional – the jurisdiction where many of the important initiatives in psychedelic medicine are emanating and where the company plans to roll out new clinical entities within significant urban population centers.”

To view the full press release, visit http://cnw.fm/jG11h

About Champignon Brands Inc.

Champignon Brands Inc. is a research-driven company specializing in the formulation of a suite of medicinal mushrooms health products, as well as novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries. Via its vertically integrated alternative medicine product range, Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting pre-clinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com